ADAMTS13 Plays a Novel Role in Hyperfibrinolysis After Trauma-Induced Shock
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, reposted from Derek Kleinveld on LinkedIn:
”Thank you Derek Kleinveld for the opportunity to collaborate with my group.”
Quoting Derek Kleinveld‘s post:
”Happy to share our latest publication on a novel role for ADAMTS13 in trauma-induced shock. Thanks to all collaborators!”
Title: A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock
Authors: Pieter H. Sloos, Lisa Vermeersch, Daphne S. Roozendaal, Anne-Sophie Delmote, Cornelis van ‘t Veer, Thomas O. Momanyi, Frida Z. Miranda, Joshua Muia, Claudia Tersteeg, Karen Vanhoorelbeke, Nicole P. Juffermans, Derek J.B. Kleinveld
Read the full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy